Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Rockefeller
Sloan Kettering
Tri-Institutional MD-PhD Program
Explore this Website
Home
About Us
Toggle About Us menu options
Welcome from Dr. Katharine Hsu
Welcome from Tri-I Students
Leadership and Staff
Our Institutions
Contact Us
Getting to the Tri-Institutional Campus
Equal Education & Employment
Admissions
Toggle Admissions menu options
Transfer Policy
Admissions FAQs
Financial Support
Finance FAQs
Curriculum and Community
Toggle Curriculum and Community menu options
Program at a Glance
MD-PhD Specific Courses and Seminars
Tri-I Faculty
Our Students
Belonging at Tri-I
MD-PhD Houses
Student Housing
Life in New York City
Program FAQ
Tri-I Outcomes
Toggle Tri-I Outcomes menu options
Fellowships and Awards
Student Publications
Thesis Defenses
Residency Matches
Academic Career Progression
Career Paths of Our Alumni
Summer Program
Toggle Summer Program menu options
Gateways Admissions
Gateways To The Laboratory Summer Program FAQ
News and Events
Toggle News and Events menu options
Events Calendar
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Admissions
Curriculum and Community
Tri-I Outcomes
Summer Program
News and Events
Home
Biblio
Found 1 results
Filters:
Keyword
is
Urokinase-Type Plasminogen Activator
[Clear All Filters]
2015
Walsh LA, Roy DM, Reyngold M, Giri D, Snyder A, Turcan S, Badwe CR, Lyman J, Bromberg J, King TA et al.
. 2015.
RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch.
.
Oncogene. 34(17):2189-203.